Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2022

Fair Value Disclosures [Abstract]

Schedule of Carrying and Estimated Fair Value of Other Financial Instruments

The table below presents the carrying amounts and estimated fair values of our financial instruments by hierarchy level as of March 31, 2022 and December 31, 2021:

	March 31, 2022
			Hierarchy Level (Fair Value)
	Carrying Amount		Level 1		Level 2		Level 3
Liabilities
Acquisition-related contingent consideration (1)(2)	$	14,956	$	—	$	—	$	14,956
2023 Convertible Notes (3)	313,936		—		505,503		—
Total	$	328,892	$	—	$	505,503	$	14,956

	December 31, 2021
			Hierarchy Level (Fair Value)
	Carrying Amount		Level 1		Level 2		Level 3
Liabilities
Acquisition-related contingent consideration (1)	$	15,110	$	—	$	—	$	15,110
2023 Convertible Notes (3)	297,158		—		466,619		—
Total	$	312,268	$	—	$	466,619	$	15,110

(1)The short-term portion is included in “Accounts payable, accrued expenses and other” and the long-term portion is included in “Other liabilities” on the Condensed Consolidated Balance Sheets.

(2)During the three months ended March 31, 2022, we acquired a business that was assigned to our Corporate Finance segment and recorded an acquisition-related contingent consideration liability.

(3)The carrying value as of March 31, 2022 includes unamortized deferred debt issuance costs. The carrying value as of December 31, 2021 includes unamortized deferred debt issuance costs and debt discount.

Schedule of Acquisition-Related Contingent Consideration

The change in our liability for acquisition-related contingent consideration for our Level 3 financial instruments is as follows:

	Contingent Consideration
Balance at December 31, 2021	$	15,110
Additions (1)	5,370
Accretion expense (2)	(979)
Payments	(4,430)
Foreign currency translation adjustment (3)	(115)
Balance at March 31, 2022	$	14,956

	Contingent Consideration
Balance at December 31, 2020	$	20,118
Accretion expense (2)	1,289
Payments	(1,000)
Foreign currency translation adjustment (3)	(612)
Balance at March 31, 2021	$	19,795

(1)During the three months ended March 31, 2022, we acquired a business that was assigned to the Corporate Finance segment.

(2)Accretion expense is included in SG&A expenses on the Condensed Consolidated Statements of Comprehensive Income.

(3)Foreign currency translation adjustments are included in "Other comprehensive loss, net of tax" on the Condensed Consolidated Statements of Comprehensive Income.